Breast Cancer Clinical Trial

Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial

Summary

The purpose of this acute study is to compare the combined effects of aerobic exercise and relaxation training on fatigue and its related cognitive components, among breast cancer survivors. Participants will complete three sessions over a seven-day period in a laboratory setting.

View Full Description

Full Description

It is hypothesized that the combination of aerobic exercise and relaxation training could have additive effects on fatigue and related cognitive outcomes. Therefore, this study is designed to test the effects of exercise plus relaxation relative to aerobic exercise alone and relaxation training alone, over the course of three sessions within a seven day period. Participants will complete baseline and post-testing before and after the week of training, as well as pre- and post-testing at each session.

Participants will be randomized to one of three conditions:

Aerobic Exercise Only Condition (AERO) Participants randomized to the AERO condition will engage in three separate 20-minute sessions comprised of a 5-minute, resistance-free warm-up, and 15 minutes of moderate aerobic cycling on a stationary bike (50-70% age-predicted heart rate max). Each AERO session will end with a 20-minute quiet rest period.
Relaxation Only Condition (RELAX) Participants in the RELAX condition will complete three separate 20-minute sessions of relaxation training using a commercial neurofeedback device (headset & smartphone app). Each RELAX session will end with a 20-minute quiet rest period.
Aerobic Exercise and Relaxation Training - Intervention Condition (COMBINED) Participants randomized to the COMBINED condition will complete three separate sessions comprised of 20 minutes of AERO exercise followed by 20 minutes of RELAX training.

All participants, regardless of condition will complete brief questionnaires assessing in-the-moment fatigue and affect, before and after each randomly assigned activity session. A larger survey and battery of cognitive tests will be completed at the beginning of the first appointment and at the conclusion of the third appointment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years and older
previously diagnosed with breast cancer (ductal carcinoma in situ or stages I-IV)
completed at least one cycle of chemotherapy treatment within the last 5 years
must have reliable access to the internet
must report at least one complaint concerning physical function, fatigue, memory, planning, thinking, negative mood, depressive symptoms, or anxiety
must be capable of engaging in sustained stationary cycling at a moderate intensity

Exclusion Criteria:

deaf in both ears
unable to comfortably wear a pair of ear-bud headphones
color-blind or do not have vision of at least 20/40 with the aid of contacts or glasses
history or diagnosis of epilepsy

Study is for people with:

Breast Cancer

Estimated Enrollment:

40

Study ID:

NCT03702712

Recruitment Status:

Completed

Sponsor:

University of Illinois at Urbana-Champaign

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Illinois at Urbana-Champaign
Urbana Illinois, 61801, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

40

Study ID:

NCT03702712

Recruitment Status:

Completed

Sponsor:


University of Illinois at Urbana-Champaign

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider